This menu provides the list of EV proteins identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Protein name UniProt accession Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization.
Proteomics. 2006 Jan;6(1):153-71.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Exosomes with immune modulatory features are present in human breast milk.
J Immunol. 2007 Aug 1;179(3):1969-78.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Protein composition of human epididymosomes collected during surgical vasectomy reversal: a proteomic and genomic approach.
Hum Reprod. 2008 Aug;23(8):1698-707. doi: 10.1093/humrep/den181. Epub 2008 May 14.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Large-scale proteomics and phosphoproteomics of urinary exosomes.
J Am Soc Nephrol. 2009 Feb;20(2):363-79. doi: 10.1681/ASN.2008040406. Epub 2008 Dec 3.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis.
J Proteome Res. 2009 Jul;8(7):3346-54. doi: 10.1021/pr801102c.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis.
J Proteome Res. 2009 Jul;8(7):3346-54. doi: 10.1021/pr801102c.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis.
J Proteome Res. 2009 Jul;8(7):3346-54. doi: 10.1021/pr801102c.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis.
Immunol Cell Biol. 2010 Nov-Dec;88(8):851-6. doi: 10.1038/icb.2010.64. Epub 2010 May 11.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT).
Proteomics. 2012 Jan;12(2):329-38. doi: 10.1002/pmic.201100477. Epub 2011 Dec 16.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages.
J Immunol. 2012 Jul 15;189(2):744-54. doi: 10.4049/jimmunol.1102244. Epub 2012 Jun 18.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages.
J Immunol. 2012 Jul 15;189(2):744-54. doi: 10.4049/jimmunol.1102244. Epub 2012 Jun 18.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Quantitative proteomic analysis of exosomes from HIV-1-infected lymphocytic cells.
Proteomics. 2012 Jul;12(13):2203-11. doi: 10.1002/pmic.201100376.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Quantitative proteomic analysis of exosomes from HIV-1-infected lymphocytic cells.
Proteomics. 2012 Jul;12(13):2203-11. doi: 10.1002/pmic.201100376.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases.
PLoS One. 2012;7(11):e49726. doi: 10.1371/journal.pone.0049726. Epub 2012 Nov 20.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases.
PLoS One. 2012;7(11):e49726. doi: 10.1371/journal.pone.0049726. Epub 2012 Nov 20.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions.
Proteomics. 2013 Jul;13(14):2125-34. doi: 10.1002/pmic.201200323.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Modulation of B-cell exosome proteins by gamma herpesvirus infection.
Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):E2925-33. doi: 10.1073/pnas.1303906110. Epub 2013 Jul 1.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Modulation of B-cell exosome proteins by gamma herpesvirus infection.
Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):E2925-33. doi: 10.1073/pnas.1303906110. Epub 2013 Jul 1.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Characterization of human thymic exosomes.
PLoS One. 2013 Jul 2;8(7):e67554. doi: 10.1371/journal.pone.0067554. Print 2013.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Characterization of multiple myeloma vesicles by label-free relative quantitation.
Proteomics. 2013 Oct;13(20):3013-29. doi: 10.1002/pmic.201300142.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Characterization of multiple myeloma vesicles by label-free relative quantitation.
Proteomics. 2013 Oct;13(20):3013-29. doi: 10.1002/pmic.201300142.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Quantitative proteomics of extracellular vesicles released from human monocyte-derived macrophages upon beta-glucan stimulation.
J Proteome Res. 2014 May 2;13(5):2468-77. doi: 10.1021/pr4012552. Epub 2014 Apr 16.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
J Proteomics. 2014 Jun 25;106:191-204. doi: 10.1016/j.jprot.2014.04.028. Epub 2014 Apr 24.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Human T-lymphotropic Virus Type 1-infected Cells Secrete Exosomes That Contain Tax Protein.
J Biol Chem. 2014 Aug 8;289(32):22284-305. doi: 10.1074/jbc.M114.549659. Epub 2014 Jun 17.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets.
Transfusion. 2014 Oct 21. doi: 10.1111/trf.12874.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets.
Transfusion. 2014 Oct 21. doi: 10.1111/trf.12874.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903A New Workflow for Proteomic Analysis of Urinary Exosomes and Assessment in Cystinuria Patients.
J Proteome Res. 2014 Nov 12.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Human thymic epithelial primary cells produce exosomes carrying tissue-restricted antigens.
Immunol Cell Biol. 2015 Mar 17. doi: 10.1038/icb.2015.33.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts.
Blood. 2015 Jun 22. pii: blood-2014-12-618025.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts.
Blood. 2015 Jun 22. pii: blood-2014-12-618025.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts.
Blood. 2015 Jun 22. pii: blood-2014-12-618025.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts.
Blood. 2015 Jun 22. pii: blood-2014-12-618025.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes.
Proc Natl Acad Sci U S A. 2016 Feb 8. pii: 201521230.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes.
Proc Natl Acad Sci U S A. 2016 Feb 8. pii: 201521230.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes.
Proc Natl Acad Sci U S A. 2016 Feb 8. pii: 201521230.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes.
Proc Natl Acad Sci U S A. 2016 Feb 8. pii: 201521230.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic and bioinformatic characterization of extracellular vesicles released from human macrophages upon influenza A virus infection.
J Proteome Res. 2016 Oct 11.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic and bioinformatic characterization of extracellular vesicles released from human macrophages upon influenza A virus infection.
J Proteome Res. 2016 Oct 11.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression.
Eur J Pharm Sci. 2016 Oct 14. pii: S0928-0987(16)30431-6. doi: 10.1016/j.ejps.2016.10.008.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression.
Eur J Pharm Sci. 2016 Oct 14. pii: S0928-0987(16)30431-6. doi: 10.1016/j.ejps.2016.10.008.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Multiple extracellular vesicle types in peritoneal dialysis effluent are prominent and contain known biomarkers.
PLoS One. 2017 Jun 8;12(6):e0178601. doi: 10.1371/journal.pone.0178601. eCollection 2017.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Multiple extracellular vesicle types in peritoneal dialysis effluent are prominent and contain known biomarkers.
PLoS One. 2017 Jun 8;12(6):e0178601. doi: 10.1371/journal.pone.0178601. eCollection 2017.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method.
J Extracell Vesicles. 2017 Apr 28;6(1):1313091. doi: 10.1080/20013078.2017.1313091. eCollection 2017.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method.
J Extracell Vesicles. 2017 Apr 28;6(1):1313091. doi: 10.1080/20013078.2017.1313091. eCollection 2017.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method.
J Extracell Vesicles. 2017 Apr 28;6(1):1313091. doi: 10.1080/20013078.2017.1313091. eCollection 2017.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Quantitation of putative colorectal cancer biomarker candidates in serum extracellular vesicles by targeted proteomics.
Sci Rep. 2017 Oct 6;7(1):12782. doi: 10.1038/s41598-017-13092-x.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
Ann Oncol. 2017 Sep 25. doi: 10.1093/annonc/mdx542.
ENOG410YHX981 / 0 / 81
HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)P01903Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
Ann Oncol. 2017 Sep 25. doi: 10.1093/annonc/mdx542.
ENOG410YHX981 / 0 / 81
[1]